Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Late Fatal Infections Remains Frequent Cause of Mortality in Pediatric Allogeneic Stem Cell Transplant Recipients

Maxim Norkin, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, Ruta Brazauskas, PhD, Heather R. Millard, MPH, Mary E. Flowers, MD, Minoo Battiwalla, MD, Bipin N. Savani, MD, Marcie L. Riches, MDMS, Juan Gea-Banacloche, MD, John R. Wingard, MD

Blood (2017) 130 (Supplement 1): 334.

https://doi.org/10.1182/blood.V130.Suppl_1.334.334

Published: 2017

Journal Articles

Late Fatal Infections Remain Higher Than Expected in Adults Receiving Allogeneic Stem Cell Transplant

Blood (2017) 130 (Supplement 1): 335.

https://doi.org/10.1182/blood.V130.Suppl_1.335.335

Published: 2017

Journal Articles

Lifestyle Factors and Subsequent Ischemic Heart Disease Risk after Hematopoietic Cell Transplantation

Kasey J Leger, MD MSc, K. Scott Baker, MD MS, Kara Cushing-Haugen, MS, Mary E. Flowers, MD, Wendy M. Leisenring, ScD, Paul J. Martin, MD, Jason A. Mendoza, MD MPH, Kerryn Reding, RN, PhD, Karen L. Syrjala, PhD, Stephanie J Lee, MD MPH, Eric J Chow, MD MPH

Blood (2017) 130 (Supplement 1): 3269.

https://doi.org/10.1182/blood.V130.Suppl_1.3269.3269

Published: 2017

Journal Articles

Long-Term Follow up of 90 y-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B-Cell Lymphoma

Camille E. Puronen, MD, Ryan D. Cassaday, MD, Philip A. Stevenson, MS, Brenda M. Sandmaier, MD, Mary E. Flowers, MD, Damian J. Green, MD, David G. Maloney, MD PhD, Rainer F. Storb, MD, Oliver W. Press, MD PhD, Ajay K. Gopal, MD

Blood (2017) 130 (Supplement 1): 4559.

https://doi.org/10.1182/blood.V130.Suppl_1.4559.4559

Published: 2017

Journal Articles

Ibrutinib Inhibits cGVHD Pathogenic Pre-Germinal Center B-Cells and Follicular Helper Cells While Preserving Immune Memory and Th1 T-Cells

Blood (2017) 130 (Supplement 1): 4481.

https://doi.org/10.1182/blood.V130.Suppl_1.4481.4481

Published: 2017

Journal Articles

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

Blood (2017) 130 (Supplement 1): 72.

https://doi.org/10.1182/blood.V130.Suppl_1.72.72

Published: 2017

Journal Articles

Comparison of Chronic Graft-Versus-Host Disease Severity and Functional Status after Cord Blood, Haploidentical Related and 1-Allele Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Giancarlo Fatobene, MD, Barry E. Storer, PhD, Rachel B. Salit, MD, Stephanie J. Lee, MD PhD, Paul J. Martin, MD, Guang-Shing Cheng, MD, Colleen Delaney, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD, Filippo Milano, MD PhD, Mary E. Flowers, MD

Blood (2017) 130 (Supplement 1): 73.

https://doi.org/10.1182/blood.V130.Suppl_1.73.73

Published: 2017

Journal Articles

Total Body Irradiation (TBI) Dose Escalation Decreases Risk of Progression and Graft Rejection after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Myelodysplastic Syndrome (MDS) or Myeloproliferative Neoplasms (MPN)

Federico Monaco, MD, Bart L. Scott, MD, Thomas Chauncey, MD PhD, Finn Petersen, MD, Barry E. Storer, PhD, Frederic Baron, Mary E. Flowers, MD, H. Joachim Deeg, MD, Rainer F. Storb, MD, David G. Maloney, MD PhD, Brenda M. Sandmaier, MD

Blood (2017) 130 (Supplement 1): 908.

https://doi.org/10.1182/blood.V130.Suppl_1.908.908

Published: 2017

Journal Articles

Quality of Life of Informal Caregivers of Hematopoietic Cell Transplant Recipients

Kareem Jamani, MD, Lynn E. Onstad, ScM, Rachel B. Salit, MD, Mary E. Flowers, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD PhD

Blood (2017) 130 (Supplement 1): 280.

https://doi.org/10.1182/blood.V130.Suppl_1.280.280

Published: 2017

Journal Articles

Prevalence and Risk-Factors for Financial Burden in Patients with Chronic Graft-Versus-Host Disease: A Cross-Sectional Survey from the Chronic Gvhd Consortium

Nandita Khera, MD, Madan Jagasia, MD MBBS, MS, Raewyn Broady, MBChB, FRACP, Lynn E. Onstad, ScM, Betty K. Hamilton, MD, George Chen, MD, Amin M. Alousi, Stefanie Sarantopoulos, MD PhD, Joseph Pidala, MD PhD, Mary E. Flowers, MD, Philip L. McCarthy, MD, Mukta Arora, MD, Corey Cutler, MD MPH, FRCPC, William A. Wood, MD MPH, Alex Ganetsky, PharmD, Gregory A. Abel, MD, Navneet S. Majhail, MD MS, Stephanie J Lee, MD MPH

Blood (2017) 130 (Supplement 1): 530.

https://doi.org/10.1182/blood.V130.Suppl_1.530.530

Published: 2017

Journal Articles

Graft-Vs-Leukemia Effect in Acute Lymphoblastic Leukemia: Mild Acute Graft-Vs-Host Disease Protects Against Relapse and Improves Survival after Allogeneic Transplantation: A CIBMTR Analysis

Moshe Yeshurun, Daniel J. Weisdorf, MD, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Mary E. Flowers, MD, Marcos De Lima, MD, Jacob M. Rowe, MD, Brenda M. Sandmaier, MD, Martin S. Tallman, MD, Michael R Verneris, MD, Veronika Bachanova, MD PhD

Blood (2017) 130 (Supplement 1): 518.

https://doi.org/10.1182/blood.V130.Suppl_1.518.518

Published: 2017

Journal Articles

Multicenter Open-Label Phase 2 Study of Ibrutinib in Chronic Graft Versus Host Disease (cGVHD) after Failure of Corticosteroids

David Miklos, MD, Corey S. Cutler, MD MPH, Mukta Arora, MD, Edmund K. Waller, MD PhD FACP, Madan Jagasia, MD MBBS, MS, Iskra Pusic, MD, Mary E. Flowers, MD, Aaron C. Logan, MD PhD, Ryotaro Nakamura, MD, Bruce R. Blazar, MD, Yunfeng Li, PhD, Indu Lal, MD, Jason Dubovsky, PhD, Danelle F. James, MD, Lori Styles, MD, Samantha Jaglowski, MD PhD

Blood (2016) 128 (22): LBA-3.

https://doi.org/10.1182/blood.V128.22.LBA-3.LBA-3

Published: 2016

Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS

Blood (2014) 124 (21): 4383.

https://doi.org/10.1182/blood.V124.21.4383.4383

Published: 2014

Journal Articles

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Stephanie J. Lee, MD MPH, Paul A. Carpenter, MD, Edus Houston Warren, MD PhD, Michael Boeckh, MD, Barry E. Storer, PhD, David Levine, PhD, Wenhong Fan, Lue Ping Zhao, PhD, John A. Hansen, MD

Blood (2014) 124 (21): 665.

https://doi.org/10.1182/blood.V124.21.665.665

Published: 2014

Journal Articles

A Pilot Study Evaluating the Safety and Efficacy of Imatinib Given Early after Transplant for High-Risk Philadelphia Chromosome-Postive Leukemias.

Paul A. Carpenter, MD, David S. Snyder, MD, Mary E. Flowers, MD, Jean E. Sanders, MD, Paul J. Martin, MD, Jerald P. Radich, MD

Blood (2005) 106 (11): 1095.

https://doi.org/10.1182/blood.V106.11.1095.1095

Published: 2005

Journal Articles

Risk Factors for Second Malignancies after Transplantation Differ between Allogeneic and Autologous Transplantation.

Debra L. Friedman, MD, MS, Wendy Leisenring, PhD, Mary E. Flowers, MD, Leona Holmberg, MD, PhD, Jeffrey Schwartz, PhD, H. Joachim Deeg, MD

Blood (2005) 106 (11): 1121.

https://doi.org/10.1182/blood.V106.11.1121.1121

Published: 2005

Journal Articles

Chronic Cutaneous GVHD Does Not Correlate with Frequency and FoxP3 Gene Expression of Regulatory T Cells.

Peter Haeusermann, MD, Laura Tabellini, Mary E. Flowers, MD, Paul J. Martin, MD, Paul A. Carpenter, MD, John A. Hansen, MD

Blood (2005) 106 (11): 1819.

https://doi.org/10.1182/blood.V106.11.1819.1819

Published: 2005

Journal Articles

Unrelated Donor Stem Cell Transplantation for 36 Patients(pts) with Fanconi Anemia(FA): A Single Center Experience.

Carmem M.S. Bonfim, MD, Marco A. Bitencourt, MD, Daniela C. Setubal, MD, Vaneuza A. Funke, MD, Carlos R. deMedeiros, MD, Jefferson Ruiz, MD, Mary E. Flowers, MD, Jose Zanis-Neto, MD, Ricardo Pasquini, MD

Blood (2004) 104 (11): 5171.

https://doi.org/10.1182/blood.V104.11.5171.5171

Published: 2004

NARROW

Late Fatal Infections Remains Frequent Cause of Mortality in Pediatric Allogeneic Stem Cell Transplant Recipients

Late Fatal Infections Remain Higher Than Expected in Adults Receiving Allogeneic Stem Cell Transplant

Lifestyle Factors and Subsequent Ischemic Heart Disease Risk after Hematopoietic Cell Transplantation

Long-Term Follow up of 90 y-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B-Cell Lymphoma

Ibrutinib Inhibits cGVHD Pathogenic Pre-Germinal Center B-Cells and Follicular Helper Cells While Preserving Immune Memory and Th1 T-Cells

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

Comparison of Chronic Graft-Versus-Host Disease Severity and Functional Status after Cord Blood, Haploidentical Related and 1-Allele Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Total Body Irradiation (TBI) Dose Escalation Decreases Risk of Progression and Graft Rejection after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Myelodysplastic Syndrome (MDS) or Myeloproliferative Neoplasms (MPN)

Quality of Life of Informal Caregivers of Hematopoietic Cell Transplant Recipients

Prevalence and Risk-Factors for Financial Burden in Patients with Chronic Graft-Versus-Host Disease: A Cross-Sectional Survey from the Chronic Gvhd Consortium

Graft-Vs-Leukemia Effect in Acute Lymphoblastic Leukemia: Mild Acute Graft-Vs-Host Disease Protects Against Relapse and Improves Survival after Allogeneic Transplantation: A CIBMTR Analysis

Multicenter Open-Label Phase 2 Study of Ibrutinib in Chronic Graft Versus Host Disease (cGVHD) after Failure of Corticosteroids

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

A Pilot Study Evaluating the Safety and Efficacy of Imatinib Given Early after Transplant for High-Risk Philadelphia Chromosome-Postive Leukemias.

Risk Factors for Second Malignancies after Transplantation Differ between Allogeneic and Autologous Transplantation.

Chronic Cutaneous GVHD Does Not Correlate with Frequency and FoxP3 Gene Expression of Regulatory T Cells.

Unrelated Donor Stem Cell Transplantation for 36 Patients(pts) with Fanconi Anemia(FA): A Single Center Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only